Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Analyzing the Role of MicroRNAs in Schizophrenia in the Context of Common Genetic Risk Variants
Mads E. Hauberg, Panos Roussos, Jakob Grove, et al.
JAMA Psychiatry (2016) Vol. 73, Iss. 4, pp. 369-369
Open Access | Times Cited: 89

Showing 1-25 of 89 citing articles:

Dysregulation of miRNA-9 in a Subset of Schizophrenia Patient-Derived Neural Progenitor Cells
Aaron Topol, Shijia Zhu, Brigham J. Hartley, et al.
Cell Reports (2016) Vol. 15, Iss. 5, pp. 1024-1036
Open Access | Times Cited: 121
The transcription factor POU3F2 regulates a gene coexpression network in brain tissue from patients with psychiatric disorders
Chao Chen, Qingtuan Meng, Yan Xia, et al.
Science Translational Medicine (2018) Vol. 10, Iss. 472
Open Access | Times Cited: 96
Non-Coding RNAs in Neurological and Neuropsychiatric Disorders: Unraveling the Hidden Players in Disease Pathogenesis
Mirolyuba Ilieva
Cells (2024) Vol. 13, Iss. 12, pp. 1063-1063
Open Access | Times Cited: 12
Alteration of microRNA expression in lymphocytes in patients with first-episode schizophrenia
Jingjing Huang, Xuyi Wang
BMC Psychiatry (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
DRD2 co-expression network and a related polygenic index predict imaging, behavioral and clinical phenotypes linked to schizophrenia
Giulio Pergola, Pasquale Di Carlo, Enrico D’Ambrosio, et al.
Translational Psychiatry (2017) Vol. 7, Iss. 1, pp. e1006-e1006
Open Access | Times Cited: 70
Dysregulation of miRNA and its potential therapeutic application in schizophrenia
Ting Cao, Xuechu Zhen
CNS Neuroscience & Therapeutics (2018) Vol. 24, Iss. 7, pp. 586-597
Open Access | Times Cited: 69
New considerations for hiPSC-based models of neuropsychiatric disorders
Gabriel E. Hoffman, Nadine Schrode, Erin Flaherty, et al.
Molecular Psychiatry (2018) Vol. 24, Iss. 1, pp. 49-66
Open Access | Times Cited: 68
microRNAs Sculpt Neuronal Communication in a Tight Balance That Is Lost in Neurological Disease
Kristen T. Thomas, Christina Groß, Gary J. Bassell
Frontiers in Molecular Neuroscience (2018) Vol. 11
Open Access | Times Cited: 53
MicroRNAs in the Onset of Schizophrenia
Kristen T. Thomas, Stanislav S. Zakharenko
Cells (2021) Vol. 10, Iss. 10, pp. 2679-2679
Open Access | Times Cited: 41
Plasma miRNAs as potential biomarkers for schizophrenia in a Jordanian cohort
Mohammad Shboul, Amal Bani Domi, A. Zahra, et al.
Non-coding RNA Research (2024) Vol. 9, Iss. 2, pp. 350-358
Open Access | Times Cited: 5
Differential activity of transcribed enhancers in the prefrontal cortex of 537 cases with schizophrenia and controls
Mads E. Hauberg, John F. Fullard, Lingxue Zhu, et al.
Molecular Psychiatry (2018) Vol. 24, Iss. 11, pp. 1685-1695
Open Access | Times Cited: 45
MicroRNAs as biomarkers for psychiatric disorders with a focus on autism spectrum disorder: Current progress in genetic association studies, expression profiling, and translational research
Yubin Hu, Erik A. Ehli, Dorret I. Boomsma
Autism Research (2017) Vol. 10, Iss. 7, pp. 1184-1203
Open Access | Times Cited: 44
Tracing Early Neurodevelopment in Schizophrenia with Induced Pluripotent Stem Cells
Ruhel Ahmad, Vincenza Sportelli, Michael J. Ziller, et al.
Cells (2018) Vol. 7, Iss. 9, pp. 140-140
Open Access | Times Cited: 42
Temporal dynamics of miRNAs in human DLPFC and its association with miRNA dysregulation in schizophrenia
Zhonghua Hu, Shouguo Gao, Daniel M. Lindberg, et al.
Translational Psychiatry (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 40
Neuronal Development-Related miRNAs as Biomarkers for Alzheimer's Disease, Depression, Schizophrenia and Ionizing Radiation Exposure
Renu Chandra Segaran, Li Yun Chan, Hong Wang, et al.
Current Medicinal Chemistry (2020) Vol. 28, Iss. 1, pp. 19-52
Closed Access | Times Cited: 37
MiR-574-5P, miR-1827, and miR-4429 as Potential Biomarkers for Schizophrenia
Omran Davarinejad, Sajad Najafi, Hossein Zhaleh, et al.
Journal of Molecular Neuroscience (2021) Vol. 72, Iss. 2, pp. 226-238
Open Access | Times Cited: 28
Amygdalar expression of the microRNA miR‐101a and its target Ezh2 contribute to rodent anxiety‐like behaviour
Joshua L. Cohen, Nateka L. Jackson, Mary E. Ballestas, et al.
European Journal of Neuroscience (2017) Vol. 46, Iss. 7, pp. 2241-2252
Open Access | Times Cited: 34
Identification of serum microRNAs as diagnostic biomarkers for schizophrenia
Kuanjun He, Chuang Guo, Meng Guo, et al.
Hereditas (2019) Vol. 156, Iss. 1
Open Access | Times Cited: 31
Neurodevelopment regulators miR-137 and miR-34 family as biomarkers for early and adult onset schizophrenia
Bao-Yu Chen, Jin-Jia Lin, Ming-Kun Lu, et al.
Schizophrenia (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 27
Identification of Peripheral Blood miRNA Biomarkers in First-Episode Drug-Free Schizophrenia Patients Using Bioinformatics Strategy
Mengdi Jin, Xiaojing Zhu, Yaoyao Sun, et al.
Molecular Neurobiology (2022) Vol. 59, Iss. 8, pp. 4730-4746
Closed Access | Times Cited: 19
miRNA profiling of hiPSC-derived neurons from monozygotic twins discordant for schizophrenia
Noora Räsänen, Jari Tiihonen, Marja Koskuvi, et al.
Schizophrenia (2025) Vol. 11, Iss. 1
Open Access
Newer insights into the role of miRNA a tiny genetic tool in psychiatric disorders: focus on post-traumatic stress disorder
Vijayasree V. Giridharan, Rajarajan A. Thandavarayan, Gabriel R. Fries, et al.
Translational Psychiatry (2016) Vol. 6, Iss. 11, pp. e954-e954
Open Access | Times Cited: 30
Mental Illnesses-Associated Fxr1 and Its Negative Regulator Gsk3β Are Modulators of Anxiety and Glutamatergic Neurotransmission
Jivan Khlghatyan, Alesya Evstratova, Simon Chamberland, et al.
Frontiers in Molecular Neuroscience (2018) Vol. 11
Open Access | Times Cited: 30
Schizophrenia risk variants affecting microRNA function and site-specific regulation of NT5C2 by miR-206
Mads E. Hauberg, Marie Hebsgaard Holm‐Nielsen, Manuel Mattheisen, et al.
European Neuropsychopharmacology (2016) Vol. 26, Iss. 9, pp. 1522-1526
Closed Access | Times Cited: 28
Epigenetic dysregulation in various types of cells exposed to extremely low-frequency magnetic fields
Gianfranco Giorgi, Brunella Del Re
Cell and Tissue Research (2021) Vol. 386, Iss. 1, pp. 1-15
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top